"
Team:BIOSINT Mexico/pitch
From 2012e.igem.org
| Line 149: | Line 149: | ||
<div class="p-border"> | <div class="p-border"> | ||
<div class="wrap"> | <div class="wrap"> | ||
| - | <p class="clr-1"><strong>Executive summary</strong></p> | + | <p class="clr-1"><strong>Executive summary.</strong></p> |
</div> | </div> | ||
<p>Continuous advances in biological science have led to the broadening of commercially available molecular biology reagents and equipment, from where many techniques, applications, products and services for both industry and laboratory have developed.</br></br> | <p>Continuous advances in biological science have led to the broadening of commercially available molecular biology reagents and equipment, from where many techniques, applications, products and services for both industry and laboratory have developed.</br></br> | ||
| Line 165: | Line 165: | ||
</p> | </p> | ||
</div> | </div> | ||
| - | </div> | + | </div> |
| + | <div class="wrap top-9"> | ||
| + | <div class="p-border"> | ||
| + | <div class="wrap"> | ||
| + | <p class="clr-1"><strong>Source data.</strong></p> | ||
| + | </div> | ||
| + | <p>Continuous advances in biological science have led to the broadening of commercially available molecular biology reagents and equipment, from where many techniques, applications, products and services for both industry and laboratory have developed.</br></br> | ||
| + | Latin America is a region with great potential in market development and expansion.</br></br> | ||
| + | |||
| + | Consolidating a Synthetic Biology enterprise that provides custom synthetically designed and optimized genes, recombinant proteins, and specialized biotechnological solutions in the region, would capture the existing market-share and at the same time would fuel the development of a fresh new market that currently remains underexploited.</br></br> | ||
| + | |||
| + | Kuxtal Biotech has identified the need for a company that supplies quality services with both speed and an excelling customer support. The opportunities for business development of genomic technologies in Mexico have been underrated. Kuxtal Biotech intends to get a grip on the already existing market, and develop it, by supplying quality products and services with on-time deliveries, validation, and technical assistance through all the research and project development process. | ||
| + | </p> | ||
| + | </div> | ||
| + | </div> | ||
</div> | </div> | ||
Revision as of 02:52, 28 October 2012
Elevator pitch video
Business model.
Executive summary.
Continuous advances in biological science have led to the broadening of commercially available molecular biology reagents and equipment, from where many techniques, applications, products and services for both industry and laboratory have developed. Latin America is a region with great potential in market development and expansion.
Source data.
Continuous advances in biological science have led to the broadening of commercially available molecular biology reagents and equipment, from where many techniques, applications, products and services for both industry and laboratory have developed. Latin America is a region with great potential in market development and expansion. Consolidating a Synthetic Biology enterprise that provides custom synthetically designed and optimized genes, recombinant proteins, and specialized biotechnological solutions in the region, would capture the existing market-share and at the same time would fuel the development of a fresh new market that currently remains underexploited. Kuxtal Biotech has identified the need for a company that supplies quality services with both speed and an excelling customer support. The opportunities for business development of genomic technologies in Mexico have been underrated. Kuxtal Biotech intends to get a grip on the already existing market, and develop it, by supplying quality products and services with on-time deliveries, validation, and technical assistance through all the research and project development process.
